Mumtaz Saifi
Delhi, DL, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Modifiable (Sleeping Pattern and Stress) and Non-Modifiable Risk Factors Associated with Breast Cancer: A Matched Case-Control Study in Delhi, India.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: March 17, 2022
Non-amplification genetic alterations of HER2 gene in non-small cell lung carcinoma.
Journal: Journal of clinical pathology
Published: May 07, 2020
Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients.
Journal: Lung Cancer (Auckland, N.Z.)
Published: December 31, 2019
Droplet digital polymerase chain reaction offers an improvisation over conventional immunohistochemistry and fluorescent in situ hybridization for ascertaining Her2 status of breast cancer.
Journal: South Asian journal of cancer
Published: December 07, 2019
Predictive biomarkers in nonsmall cell carcinoma and their clinico-pathological association.
Journal: South Asian journal of cancer
Published: December 07, 2019
The detection of primary and secondary EGFR mutations using droplet digital PCR in patients with nonsmall cell lung cancer.
Journal: Lung India : official organ of Indian Chest Society
Published: September 01, 2018
Clinical utility of RT-PCR in assessing HER 2 gene expression versus traditional IHC and FISH in breast cancer patients.
Journal: Breast cancer (Tokyo, Japan)
Published: January 15, 2018
ROS1 rearrangement and response to crizotinib in Stage IV non-small cell lung cancer.
Journal: Lung India : official organ of Indian Chest Society
Published: September 05, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026